These findings do not per se contradict previous preclinical reports [11], because different APC/CTNNB1 genetic aberrations may variably regulate β-catenin association with various competing multiprotein complexes within melanoma cells, and therefore various tumor progression events (Supplementary File, Fig. S1) [29]. The gene discussed is CTNNB1; the disease is neoplasm.